Search and Browse
Download
Enter Data
| Reaction Details | |||
|---|---|---|---|
 | Report a problem with these data | ||
| Target | Alpha-1D adrenergic receptor | ||
| Ligand | BDBM50213521 | ||
| Substrate/Competitor | n/a | ||
| Meas. Tech. | ChEMBL_438894 (CHEMBL889237) | ||
| Ki | 0.77±n/a nM | ||
| Citation |  Chiu, G; Li, S; Connolly, PJ; Pulito, V; Liu, J; Middleton, SA (Phenylpiperidinyl)cyclohexylsulfonamides: development of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS). Bioorg Med Chem Lett17:3930-4 (2007) [PubMed] Article | ||
| More Info.: | Get all data from this article, Assay Method | ||
| Alpha-1D adrenergic receptor | |||
| Name: | Alpha-1D adrenergic receptor | ||
| Synonyms: | ADA1D_HUMAN | ADRA1A | ADRA1D | Adrenergic receptor | Adrenergic receptor alpha | Alpha 1D-adrenoceptor | Alpha 1D-adrenoreceptor | Alpha adrenergic receptor (1a and 1d) | Alpha-1D adrenoceptor | Alpha-adrenergic receptor 1a | adrenergic Alpha1D | ||
| Type: | Enzyme Catalytic Domain | ||
| Mol. Mass.: | 60485.82 | ||
| Organism: | Homo sapiens (Human) | ||
| Description: | adrenergic Alpha1D ADRA1D HUMAN::P25100 | ||
| Residue: | 572 | ||
| Sequence: |
| ||
| BDBM50213521 | |||
| n/a | |||
| Name | BDBM50213521 | ||
| Synonyms: | CHEMBL390129 | N-((1s,4s)-4-(4-(2-isopropoxyphenyl)piperidin-1-yl)cyclohexyl)-3,4-dimethoxybenzenesulfonamide | ||
| Type | Small organic molecule | ||
| Emp. Form. | C28H40N2O5S | ||
| Mol. Mass. | 516.693 | ||
| SMILES | COc1ccc(cc1OC)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OC(C)C |wU:17.21,14.14,(9.42,6.24,;7.88,6.23,;7.12,4.89,;5.57,4.87,;4.82,3.53,;5.6,2.21,;7.14,2.22,;7.9,3.56,;9.44,3.57,;10.22,2.24,;4.84,.87,;3.49,1.6,;6.19,.12,;4.12,-.5,;2.58,-.55,;1.86,-1.91,;.33,-1.97,;-.49,-.67,;.22,.69,;1.76,.75,;-2.03,-.73,;-2.75,-2.09,;-4.28,-2.16,;-5.11,-.86,;-4.4,.51,;-2.86,.57,;-6.64,-.92,;-7.36,-2.29,;-8.9,-2.36,;-9.72,-1.05,;-9.02,.31,;-7.48,.38,;-6.78,1.75,;-7.61,3.05,;-6.9,4.41,;-9.15,2.97,)| | ||
| Structure | 
| ||